GCC
EW icon

Guardian Capital (Canada)’s Edwards Lifesciences EW Stock Holding History

Guardian Capital (Canada)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,577
Closed -$200K – 152
2019
Q4 		$200K Buy
+2,577
New +$201K ﹤0.01% 162
2015
Q3 		– Sell
-18,324
Closed -$435K – 224
2015
Q2 		$435K Hold
18,324
– – 0.01% 163
2015
Q1 		$435K Sell
18,324
-3,360
-15% -$75.4K 0.01% 168
2014
Q4 		$460K Buy
+21,684
New +$436K 0.01% 183

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Guardian Capital (Canada)'s EW Position: Q1 2020 in Review

Guardian Capital (Canada) sold out of Edwards Lifesciences (EW) in Q1 2020, closing a stake of 2,577 shares — an estimated $200K sold.

Guardian Capital (Canada) first reported a position in EW in Q4 2014 and held it in 4 quarters. The position peaked at $460K in Q4 2014. 1,019 funds tracked by Wall St. Rank hold EW as of Q1 2020.

  • Guardian Capital (Canada) reported no remaining Edwards Lifesciences position as of Q1 2020 after selling out during the quarter.
  • Guardian Capital (Canada) sold 2,577 Edwards Lifesciences shares in Q1 2020, an estimated $200K.
  • Guardian Capital (Canada) first reported a position in Edwards Lifesciences in Q4 2014 and held it in 4 quarters.
  • Guardian Capital (Canada)'s Edwards Lifesciences position peaked at $460K in Q4 2014.
  • 1,019 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.

Based on Guardian Capital (Canada)'s 13F filing for Q1 2020, filed 15 May 2020.